期刊文献+

同期左心耳闭合预防二尖瓣置换术后缺血性脑卒中的早期结果 被引量:2

Early results of left atrial appendage closure in cerebral ischemic stroke reduction in patients with mitral valve replacement
原文传递
导出
摘要 目的 探讨同期闭合左心耳预防二尖瓣置换术后缺血性脑卒中的作用.方法 回顾性分析2008年1月至2013年1月住院的860例接受二尖瓣置换的成年患者临床资料,其中男性414例,女性446例,平均年龄(53±12)岁.按术中是否同期闭合左心耳分为闭合组(n=521)和非闭合组(n =339),比较分析术后住院期间缺血性脑卒中发生情况,采用Logistic逐步回归分析法分析缺血性脑卒中危险因素,探讨左心耳闭合对瓣膜置换术后缺血性脑卒中的影响.结果 闭合组女性比例较高,合并心功能不全、肺动脉高压和左心房血栓比例较高,术前左心房内径较大,植入机械瓣、同期处理三尖瓣比例较高,但合并高血压和接受冠状动脉旁路移植术比例较低,主动脉瓣阻断时间较短(χ^2 =6.807 ~122.576,t=-2.818、3.756,P值均<0.05).两组术后开胸止血和住院期间病死率差异无统计学意义(P>0.05).术后住院期间共12例患者缺血性脑卒中,发生率1.4%.闭合组缺血性脑卒中发生率低于非闭合组(0.6%比2.7%,χ^2 =6.452,P=0.011).Logistic多因素回归分析结果显示,左心耳闭合是术后住院期间缺血性脑卒中的保护因子(OR=0.189,95% CI:0.039 ~0.902,P=0.037),术前脑血管病史(OR=4.326,95% CI:1.074 ~ 17.418,P=0.039)和术前左心房内径(OR=1.059,95% CI:1.022~1.098,P=0.002)是术后缺血性脑卒中的危险因素.对术前是否合并心房颤动的亚层分析显示,左心耳闭合是预防心房颤动患者术后缺血性脑卒中的强预测因素(OR=0.064,95% CI:0.006 ~0.705,P=0.025),而对于非心房颤动患者则并非预测因素(OR=1.902,95% CI:0.171~21.191,P=0.601).结论 二尖瓣置换术同期闭合左心耳操作安全,可以降低心房颤动患者二尖瓣置换术后早期缺血性脑卒中的发生率. Objective To investigate the role of left atrial appendage (LAA) closure for cerebral ischemic stroke prevention following mitral valve replacement.Methods Retrospective data on 860 consecutive adult patients undergoing mitral valve replacement between January 2008 and January 2013 were analyzed.There were 414 male and 446 female patients,with a mean age of (53 ± 12) years.The patients were divided into two groups according to whether the left atrial appendage was closed during operation:LAA closure group (n =521) and non-LAA closure group (n =339).Early mortality,postoperative cerebral ischemic stroke and the risk factors for cerebral ischemic stroke were assessed.Multivariate analysis was performed using logistic regression analysis.Results Compared with non-LAA closure group,LAA closure group had higher proportion of female gender,higher percentage of patients with cardiac insufficiency,pulmonary hypertension and left atrial thrombus,higher incidence of mechanical valve implantation and concurrent tricuspid surgery,and larger preoperative diameter of left atrium,but lower proportion of hypertension and patients undergoing coronary artery bypass surgery,and shorter aorta cross clamping time (χ^2 =6.807 to 122.576,t =-2.818 and 3.756,all P 〈0.05).There were no differences in exploratory thoracotomy for bleeding and in-hospital mortality between the two groups.Postoperative cerebral ischemic stroke occurred in 12 patients (1.4%).The incidence of cerebral ischemic stroke in LAA closure group was significantly lower than in non-LAA closure group (0.6% vs.2.7%,χ^2 =6.452,P =0.011).Logistic regression analysis showed that LAA closure was a significant protective factor for postoperative cerebral ischemic stroke (OR =0.189,95% CI:O.039 to 0.902,P =0.037) while history of cerebrovascular disease (OR =4.326,95% CI:1.074 to 17.418,P =0.039) and preoperative diameter of left atrium (OR =1.509,95% CI:1.022 to 1.098,P =0.002) being the independent risk factors for postoperative cerebral ischemic stroke.The subgroup analysis showed that,for atrial fibrillation patients,LAA closure was a strong protective factor (OR =0.064,95% CI:0.006 to 0.705,P =0.025),but LAA closure was not a significant predictive factor (OR =1.902,95% CI:0.171 to 21.191,P =0.601) in non-atrial fibrillation patients.Conclusion Concurrent LAA closure during mitral valve replacement is safe and effective to reduce the early postoperative risk of cerebral ischemic stroke in atrial fibrillation patients.
出处 《中华外科杂志》 CAS CSCD 北大核心 2014年第12期934-938,共5页 Chinese Journal of Surgery
关键词 心脏瓣膜假体植入 心耳 脑梗塞 心房颤动 Heart valve prosthesis implantation Atrial appendage Brain infarction Atrial fibrillation
  • 相关文献

参考文献18

  • 1Bucerius J,Gummert JF,Borger MA,et al.Stroke after cardiac surgery:a risk factor analysis of 16,184 consecutive adult patients[J].Ann Thorac Surg,2003,75 (2):472-478.
  • 2Hogue CW Jr,Murphy SF,Schechtman KB,et al.Risk factors for early or delayed stroke after cardiac surgery[J].Circulation,1999,100(6):642-647.
  • 3Dawson AG,Asopa S,Dunning J.Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion.?[J].Interact Cardiovasc Thorac Surg,2010,10 (2):306-311.
  • 4Maisel WH.Left atrial appendage occlusion--closure or just the beginning?[J].N Engl J Med,2009,360 (25):2601-2603.
  • 5张振华,张海波,孟旭.预防心房颤动栓塞事件的治疗现状与进展[J].心肺血管病杂志,2013,32(5):659-662. 被引量:13
  • 6Ruel M,Masters RG,Rubens FD,et al.Late incidence and determinants of stroke after aortic and mitral valve replacement[J].Ann Thorac Surg,2004,78(1):77-83.
  • 7Bando K,Kobayashi J,Hirata M,et al.Early and late stroke after mitral valve replacement with a mechanical prosthesis:risk factor analysis of a 24-year experience[J].J Thorac Cardiovasc Surg,2003,126 (2):358-364.
  • 8A1-Saady NM,Obel OA,Camm AJ.Left atrial appendage:structure,function,and role in thromboembolism[J].Heart,1999,82(5):547-554.
  • 9Johnson WD,Ganjoo AK,Stone CD,et al.The left atrial appendage:our most lethal human attachment ! Surgical implications[J].Eur J Cardiothorac Surg,2000,17 (6):718-722.
  • 10Kanderian AS,Gillinov AM,Pettersson GB,et al.Success of surgical left atrial appendage closure:assessment by transesophageal echocardiography[J].J Am Coll Cardio1,2008,52 (11):924-929.

二级参考文献32

  • 1史爱武,陆凤翔,许迪,姚静,王晓伟,盛艳辉,杨荣,李世杰,曹克将,孔祥清.经胸超声心动图评价左心耳封堵术对猪左心房功能及二尖瓣、肺静脉血流动力学的影响[J].中华医学超声杂志(电子版),2007,4(2):67-69. 被引量:3
  • 2Heeringa J. Atrial fibrillation: is the prevalence rising? Eu- ropace,2010,12:451-452.
  • 3Zhang S. Atrial fibrillation in China's Mainland: epidemiology and current management. Heart ,2009,95 : 1052-1055.
  • 4Wolf PA,Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 1991, 22:983-988.
  • 5Villani GQ, Piepoli PE, VilIaniPE, et al. Anticoagulationin atrial fibrillation; what is certain and what is to come. Eur Heart J, 2003, (Suppl) :45-50.
  • 6Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts;implications for echocardiographic examina- tion. Circulation, 1997,96 : 3112 -3115.
  • 7Kamath S, Blann AD, Chin BS, et al. Platelet activation, haemo- rheology and thrombogenesis in acute atrialfibrillation: a compari- son with permanent atrial fibrillation, Heart, 2003,89: 1093- 1095.
  • 8Agarwal S, Hachamovitch R, Menon V, et al. Current trial-asso- ciated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: A Meta-analysis. Arch Intern Med ,2012,172:623-631.
  • 9Connolly S J, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarinpatients with atrial fibrillation. N Engl J Med, 2009, 361:1139-1151.
  • 10Eikelboom JW, Wallentin L, Connolly S J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the ran- domized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation, 2011,123 : 2363-2372.

共引文献12

同被引文献53

  • 1仲京,解士胜,万士杰,王维新,张红超,于鲁峰.国产GK-2型人造心脏瓣膜20年临床应用的随访观察[J].中华医学杂志,2005,85(37):2644-2646. 被引量:1
  • 2Nishida T, Sonoda H, Oishi Y, et al. Mechanical prosthesis is rea- sonable for mitral valve replacement in patients approximately 65 years of age[J]. Ann Thorac Surg,2013,96 (5) : 1614-1620. doi: 10. 1016/j. athoracsur. 2013.05. 014.
  • 3Azarnoush K, Laborde F, de Riberolles C. The Sorin Bicarbon over 15 years clinical outcomes: muhicentre experience in 1704 patients [J]. Eur J Cardiothorac Surg, 2010, 38 (6) :759-766. doi: 10. 1016/j. ejcts. 2010.03,060.
  • 4Dimarakis I, Grant SW, Hickey GL, et al. Mitral valve prosthesis choice for patients aged 65 years and over in the UK. Are the guide-lines being followed and does it matter? [ J]. Heart, 2014, 100 (6) :500-507. doi : 10. 1136/heartjnl-2013-304783.
  • 5Kaneko T, Aranki S, Javed Q, et al. Mechanical versus bioprosthet- ic mitral valve replacement in patients < 65 years old [ J ]. J Thorac Cardiovasc Surg, 2014, 147 ( 1 ) : 117-126. doi: 10. 1016/j. jtcvs. 2013.08. 028.
  • 6Bryan AJ, Rogers CA, Bayliss K, et al. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechani- cal heart valve prostheses : ten-year follow-up [ J ]. J Thorac Cardio- vase Surg, 2007,133 ( 3 ) :6144522.
  • 7Toole JM, Stroud MR, Kratz JM, et al. Twenty-five year experience with the St. Jude medical mechanical valve prosthesis[J]. Ann Tho- rac Surg, 2010, 89 ( 5 ) : 1402-1409. doi: 10. 1016/j. athoraesur. 2010.01. 045.
  • 8Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve sur- gery in the United States: results from the Society of Thoracic Sur- geons Adult Cardiac Surgery Database[J]. Ann Thorac Surg, 2009, 87 ( 5 ) : 1431-1439. doi : 10. 1016/j.athoraesur. 2009.01. 064.
  • 9Kim JB, Kim HJ, Moon DH, et al. Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement [ J ]. Eur J Cardiothorae Surg,2010, 37 (5) : 1039- 1046. doi : 10. 1016/j. ejcts. 2009.11. 019.
  • 10Wang B, Xu ZY, Han L, et al. ImpaCt 0f preoperative atrial fibrilla- tion on mortality and cardiovascular outcomes of mechanical mitral valve replacement for rheumatic mitral valve disease[J]. Eur J Car- diothorac Surg, 2013, 43 ( 3 ) :513-519. doi : 10. 1093/ejcts/ezs213.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部